MedPath

Prognosis Value of Non-invasive Methods for the Diagnosis of Chronic Liver Disease

Recruiting
Conditions
Chronic Liver Disease
Registration Number
NCT02060565
Lead Sponsor
Association HGE CHU Bordeaux Sud
Brief Summary

The aim of this retrospective and prospective study is to evaluate the 20-year prognosis value of non-invasive methods for the diagnosis of chronic liver disease for predicting survival and complications of cirrhosis.

Detailed Description

All consecutive patients with chronic liver disease will be followed during 20 years.

Recruitment & Eligibility

Status
RECRUITING
Sex
All
Target Recruitment
10000
Inclusion Criteria
  • chronic hepatitis C
  • chronic hepatitis B
  • alcohol liver disease
  • non alcoholic liver disease
Exclusion Criteria
  • ascitis

Study & Design

Study Type
OBSERVATIONAL
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Overall survival20 years
Secondary Outcome Measures
NameTimeMethod
Survival without liver complications20 years

Trial Locations

Locations (1)

Centre d'Investigation de la Fibrose hépatique Service Hépato-Gastroentérologie Hopital Haut-Lévèque

🇫🇷

Pessac, France

© Copyright 2025. All Rights Reserved by MedPath